Positive Impact of Home ERT for Mucopolysaccharidoses and Pompe Disease: The Lesson Learnt from the COVID-19 Pandemic
Open Access
- 19 April 2023
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 11 (8) , 1176
Abstract
Objective: Patients with Lysosomal disorders (LSDs) are treated with regular infusions of enzyme replacement therapy (ERT). During the COVID-19 pandemic, home treatment was permitted. This study aimed at monitoring the patients’ compliance with home therapy and its effects on physical, psychological, and relational issues. Moreover, we also tested the possible impact of home therapy on familial relationships and contacts with the referral hospital. Materials and Methods: Thirteen patients with Pompe disease (N = 8) and MPS (N = 5) were tested through an online questionnaire designed to assess their level of appreciation and satisfaction with home therapy and their feelings about the referral centre and psychological support provided. Results: Most of the patients (84%) stressed the positive impact of home therapy. All patients described a significant reduction in stressful conditions associated with the need to attend the hospital every week or two. Conclusions: Home ERT leads to a clear improvement in “daily life skills”, as represented in our by sample by positive feelings, better emotional self-control, and an increased ability to understand the feelings of relatives. Our data underline the paramount positive effect home ERT has on both patients and their families.Keywords
This publication has 21 references indexed in Scilit:
- Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?Blood Cells, Molecules, and Diseases, 2020
- COVID-19 Pandemic Outbreak and its Psychological Impact on Patients with Rare Lysosomal DiseasesJournal of Clinical Medicine, 2020
- Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experienceMolecular Genetics and Metabolism, 2020
- Lysosomal storage disease overviewAnnals of Translational Medicine, 2018
- Lysosomal storage diseasesNature Reviews Disease Primers, 2018
- Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative groupMolecular Genetics and Metabolism Reports, 2017
- 13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher diseaseBlood Cells, Molecules, and Diseases, 2015
- Home treatment in paediatric patients with Hunter syndrome: the first Italian experienceItalian Journal of Pediatrics, 2013
- New strategies for the treatment of lysosomal storage diseases (Review)International Journal of Molecular Medicine, 2012
- Home infusion therapy is safe and enhances compliance in patients with mucopolysaccharidosesMolecular Genetics and Metabolism, 2009